Keryx Biopharmaceuticals Initiates Phase 2 Study of Zerenex(TM) (Ferric …

Published November 17, 2012

Keryx Biopharmaceuticals Initiates Phase 2 Study of Zerenex(TM) (ferric …

Filed under: Denver Colorado Drug Treatment Centers

Geoffrey A. Block, MD, Director of Clinical Research at Denver Nephrology and Associate Clinical Professor in Medicine at the University of Colorado Health Sciences Center;. Glenn Chertow, MD, Chief, Division of Nephrology and Professor of Medicine at …
Read more on MarketWatch (press release)

More Than 850000 Coloradoans At Risk For Stroke In Their Lifetime

Filed under: Denver Colorado Drug Treatment Centers

In just our mountainous corner of the world, nearly 433,000 Denver metro area residents will experience a stroke in their lifetime. The staggering statistics: one in six – or more than 850,000 Colorado residents will experience the same. … "The MAX …
Read more on Melodika.net (press release)